By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
There are several chances for medical device businesses to fulfil the country’s expanding demand because the UAE is nearly totally dependent on medical equipment imports.
As more international manufacturers enter the UAE medical device market, distributor-mediated sales will continue to dominate since these businesses need local distributor relationships to advertise their products there.
Intelligent balloon catheters and autonomous surgical robots will improve the results of complicated operations and open the door to new minimally invasive surgical techniques.
Hospitals upgrade their medical equipment in response to high rates of lung and heart illness, which raises demand for general radiography equipment including electro-cardiographs, ultrasound, x-ray, and others. Future healthcare infrastructure developments in the UAE will also aid industry expansion.
One of the biggest markets for medical equipment in the Middle East and Africa is the UAE. The market for advanced medical equipment is very price sensitive and import-dependent, with products coming from the US, Germany, Japan, and China, among others.
The UAE Medical Devices Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.
The Middle East Division of Canon Medical Systems Corporation has officially opened in Dubai, United Arab Emirates. To commence company activities, preparations are now being made.
After more than thirty years in business, Canon Medical is dedicated to providing its clients and partners in the Middle East with the greatest support. Canon will continue to make efforts to advance healthcare and promote a healthy lifestyle for all individuals.
It has been revealed that Dubai’s Seed Group has added a Tel Aviv-based healthtech startup as a key partner. As a result of this new agreement, Healthy.io, which is well-known for its ability to turn a smartphone into a medical device, will initially establish a base in Dubai in the GCC in order to extend its activities in the region.
A strategic agreement was established by BioT Medical, a No-code connected-care platform for medical devices, and Nagarro, a worldwide digital engineering business. The Nagarro BioT collaboration exemplifies the best of two worlds: mastery of connected medical devices and superior digital engineering.
Through this agreement, device makers will be able to quickly convert any medical device into a connected care platform, creating an end-to-end, customized patient care system that is fully linked with the workflows and ecosystem of the current caregivers. Device producers can now profit from a direct-to-consumer relationship while enhancing the caregiving abilities of carers by utilizing their current processes.
It has been revealed that Israel’s Illumigyn plans to export its FDA-cleared “revolutionary” endoscope and console to the Gulf Cooperation Council (GCC). The medical device business and Digital Health Innovation (DHI), based in the United Arab Emirates, have signed a Memorandum of Understanding (MoU) to bring Gynescope systems to the area.
The Gynescope is an endoscope for pelvic exams that is non-invasive, high-resolution, and enables real-time visualization, documentation, and remote diagnosis.
SonoStik, a startup in the field of medical equipment, received an undisclosed amount from Ghadan Ventures Fund in Abu Dhabi. DisruptAD, one of the biggest venture platforms in the area and manager of the Ghadan Ventures Fund, took the lead in the initial round of fundraising, often known as the series A round.
from Abu Dhabi The SonoStik Guide Wire Introducer, a medical device with a US patent and FDA approval that aids in the successful insertion of intravenous catheters in patients, was SonoStik’s first novel product.
Healthcare professionals and caregivers from across the world have come to Dubai to witness the introduction of the Hill-Rom Centrella Smart+ bed in the UAE. The Centrella Smart+ bed, according to the company, offers improved patient safety, greater patient pleasure, and cutting-edge caregiver-focused technology.
Hill-cutting-edge Rom’s NaviCare Patient Safety System, which combines technology, services, therapeutic programs, and clinical experience to assist prevent and decrease the risk of falls, is also integrated into the Centrella Smart+ bed.
In addition to alerting caregivers to a bed that is in a dangerous condition, NaviCare works autonomously to make timely and pertinent modifications to the safety settings on the bed.
Now, the bed can continuously track the patient’s heart and breathing rates at a rate of more than 100 times per minute. EarlySense technology allows health teams to intervene more successfully by warning doctors of probable deterioration events considerably sooner than standard monitoring techniques.
As the UAE promotes its domestic manufacturing sector, US pharmaceutical technology company Gabri Labs has struck an agreement with Dubai Science Park to create a factory to manufacture medical equipment. The factory, which is 10,000 square feet in size and will produce up to 12 million units of the pharmaceutical brands manufactured by Gabri Labs each year, will undergo further expansion in the near future.
The new facility in Dubai will enable the production of numerous lines and a broad range of goods, including the dermatological solutions line Curadem and the ENT brand OTOMAR. Over 4,000 individuals work at Dubai Science Park, where the facility will be built. It has commercial areas, a central office, a lab complex, and storage facilities.
Sanifit Therapeutics, a Spanish clinical-stage cardio-renal biopharmaceutical company specializing in therapies for patients with end-stage kidney disease who have progressive vascular calcification disorders, and Inositec AG, a Swiss company creating first-in-class non-dialysis therapies for soft tissue and vascular calcification disorders, have both been acquired by Vifor Pharma.
Vifor Pharma will be able to assist a continuum of vascular calcification problems at all phases of CKD thanks to these acquisitions. According to the terms of the transaction, Vifor Pharma will purchase all of the outstanding shares of Sanifit Therapeutics for a total of 100%, as well as receive full global rights to SNF472, expanding the company’s portfolio of cutting-edge assets.
This is significant given that the world is currently battling COVID-19 and risks posed by its new varieties as the epidemic enters its third year. Access to VTD and improving the healthcare system thus became crucial elements. To prepare for the increase in COVID-19 cases and put an end to the pandemic’s acute phase, these should be improved.
The United Arab Emirates (UAE) and the Indonesian government collaborated to expand the pharmaceutical and medical device industries. Increasing research and production capacity for vaccines, therapies, and diagnostics is one of the primary areas of cooperation (VTD).
If the next epidemic occurs, this will give all nations better and equitable access. This partnership has the potential to be a significant opportunity and an excellent place to begin strengthening the global health infrastructure that was weakened by the COVID-19 epidemic.
